merck (biotechcompany)

literal strings:
  merck, Merck, MERCK
  Merck & Co, merck & co
  MERCK and CO, merck and co, Merck and Co

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• merck is a biotech company     
• merck is a company     
• merck has human agency     
• merck has acquired schering_plough (biotechcompany)     
• caspofungin is a drug worked on by merck (biotechcompany)     
• dichlorphenamide is a drug worked on by merck (biotechcompany)     
• enalapril is a drug worked on by merck (biotechcompany)     

categories

• biotechcompany(100.0%)
• CMC @1105 (100.0%) on 25-mar-2018 [ SUFFIX=erck 3.13158 SUFFIX=rck 3.09444 LASTSUFFIX=erck 2.21004 LASTSUFFIX=rck 2.20950 PREFIX=mer 1.89390 PREFIX=merc 1.56764 LASTPREFIX=mer 1.54051 FULL_WORDSHAPE=A -0.74259 FULL_POS=NN -1.07808 WORDS -1.11877 ] using merck
• CMC @1099 (100.0%) on 23-jan-2018 [ LAST_WORD=co 2.46070 SUFFIX=erck 1.70526 SUFFIX=rck 1.70463 FIRST_WORD=merck 1.61408 PREFIX=merc 1.49612 FULL_POS=NN_CC_NN 1.36502 PREFIX=mer 1.31315 CHARS -0.86567 WORDS -1.36063 SHORT_WORDSHAPE=a -4.29989 ] using merck_and_co
• OE @829 (99.5%) on 08-apr-2014 [   ] using merck
• CPL @1098 (81.7%) on 21-jan-2018 [ "pharma major _" "pharmaceutical manufacturers such as _" "vaccine is manufactured by _" "grant support from _" "_ promoted the drug" "drug developed by _" "_ 's painkiller Vioxx" "drug sold by _" "safety monitoring board for _" "Gardasil , made by _" "medicine made by _" "vaccine , developed by _" "unrestricted educational grant from _" "African subsidiary of _" "drugs giant _" "Key market players covered are _" "_ 's Gardasil" "education grant from _" "medication manufactured by _" "_ 's Sustiva" "_ 's Gardasil vaccine" "_ withdrew Vioxx" "_ 's Vioxx" "drug major _" "vaccine developed by _" "_ 's Zocor" "consumer products division of _" "biotechnology companies including _" "consulting fees from _" "pharmaceutical subsidiary of _" "players covered are _" "unrestricted research grant from _" "_ 's indinavir" "medicinal chemistry at _" "research support from _" "healthcare companies such as _" "_ 's Singulair" "unrestricted educational grants from _" "educational grant from _" "Fosamax , manufactured by _" "_ 's HIV vaccine" "products division of _" "market players covered are _" "biotech firms such as _" "educational grants from _" "speakers bureau for _" "Vioxx , made by _" "vaccine made by _" "South African subsidiary of _" "inhibitor manufactured by _" "_ 's Fosamax" "_ 's Januvia" "vaccine , made by _" ] using merck___co
• SEAL @210 (100.0%) on 15-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ] using merck
• CMC @1099 (100.0%) on 23-jan-2018 [ LAST_WORD=co 6.79577 SUFFIX=erck 2.19989 SUFFIX=rck 2.19461 PREFIX=mer 1.27782 SUFFIX=ck 1.06524 PREFIX=merc 1.01572 WORDSHAPE=x 0.85514 FULL_WORDSHAPE=Aa_x_Aa -0.17464 SHORT_WORDSHAPE=a -0.43075 WORDS -2.05812 ] using merck___co
• SEAL @214 (98.4%) on 22-feb-2011 [ 1 2 3 4 5 6 ] using merck___co
• OE @1033 (100.0%) on 25-dec-2016 [ http://www.studymode.com/essays/Merck-And-Co-River-Blindness-846240.html http://www.studymode.com/essays/Merck-And-Co-River-Blindness-846240.html http://www.studymode.com/essays/Merck-And-Co-River-Blindness-846240.html http://www.cbsnews.com/news/new-drug-offers-promise-cure-hepatitis-c/  ] using merck_and_co
• SEAL @211 (50.0%) on 17-feb-2011 [ 1 ] using merck_and_co
• CPL @1105 (75.5%) on 25-mar-2018 [ "_ developed the vaccine" "_ misled doctors" "mega corporations such as _" "comparison , rival _" "class action lawsuits have been filed against _" "drug discovery at _" "South African subsidiary of _" "It is manufactured by _" "corporate citizens such as _" "_ is seeking Food" "_ is a media monitoring service" "speakers bureaus of _" "vaccine is made by _" "_ sold the drug" "_ filed a patent infringement action" "study was sponsored by _" "vaccine made by _" "_ Gets FDA OK" "supplement was sponsored by _" "Chemicals were purchased from _" "_ 's boceprevir" "_ 's Prilosec" "FDA asked _" "Pharma companies like _" "_ 's Zetia" "other chemicals were from _" "_ pulled Vioxx" "_ is a WebMD sponsor" "discovery efforts at _" "intellectual property portfolio to _" "other reagents were purchased from _" "alternative brand to _" "action lawsuits have been filed against _" "speakers bureau for _" "chemicals business of _" "culture media were purchased from _" "consultancy fees from _" "multinational companies , such as _" "drug metabolism at _" "partnership announced by _" "trial was sponsored by _" "_ 's painkiller Vioxx" "vaccine , made by _" "class action accusing _" "animal health division of _" "drugmakers like _" "drug company called _" "Health division of _" "_ 's chemicals business" "_ 's annual filing" "Ratings information for _" "_ 's protease inhibitor" "Massachusetts sued _" "pharmaceutical firm of _" "renowned names as _" "pharmaceutical career at _" "_ 's animal health business" "Claims Act case against _" "_ 's AIDS drug" "_ 's WACC calculation" "_ 's comparative multiple analysis" "_ 's cost-cutting efforts" "well-known companies as _" "chemical company called _" "control product from _" "analytical chemist at _" "_ sued Apotex" "_ hid the risks" "_ removed Vioxx" "lectures were sponsored by _" "program is partnered with _" "registered brand name of _" "regional medical director for _" "drugmakers such as _" "drug companies , such as _" "drug company like _" "antibiotic made by _" "_ still owns the patent" "_ owns U.S. Patent No." "industry career at _" "® is manufactured by _" "pill manufactured by _" "pharma companies , including _" "_ asks FDA" "pharmaceutical company such as _" "_ expects FDA approval" "_ 's similar product" "new drug from _" "_ is conducting a Phase" "chemical companies including _" "it was patented by _" "_ announced a price" "_ 's outside legal counsel" "_ acquired the drug" "individual lawsuits against _" "independent subsidiary of _" "medication is manufactured by _" "multinational corporations like _" "company acquired by _" "educational grants from _" "multinational companies such as _" "_ 's oncology pipeline" "powerful corporations like _" "first marketed by _" "_ 's heavy promotion" "drug produced by _" "AB-rated generic equivalent of _" "_ 's cervical cancer vaccine" "_ 's Canadian subsidiary" "drug lawsuit against _" "speaking fees from _" "FDA required _" "_ misrepresented the safety" "_ is facing thousands" "volume was also seen in _" "class action lawsuits were filed against _" "educational grants provided by _" "drug companies , like _" "_ marketed the drug" "other giants such as _" "speaker bureau for _" "_ filed an NDA" "effects mentioned by _" "vaccine development at _" "Active member with _" "it is marketed by _" "health divisions of _" "_ 's BLA" "biopharmaceutical companies such as _" "_ has submitted a new drug application" "lecture honoraria from _" "you purchase is manufactured by _" "_ 's research chief" "medicinal chemist at _" "medications manufactured by _" "Gardasil , manufactured by _" "_ 's DCF analysis" "chemical engineer for _" "discovery collaboration with _" "drug manufacturers like _" "vaccine produced by _" "_ 's in-house lawyers" "_ 's patient assistance program" "_ 's global director" "_ defrauded the federal government" "_ 's Bextra" "unrestricted educational grants from _" "vaccine , developed by _" "vaccine , produced by _" "engineering firms such as _" "Chemicals division of _" "large pharmaceutical companies like _" "vaccine was produced by _" "antibody was purchased from _" "independent educational grants from _" "_ 's vaccine division" "_ sought FDA approval" "pharmaceutical manufacturers such as _" "ingredient developed by _" "inhibitor manufactured by _" "large pharmaceutical companies such as _" "joint development program with _" "grant support from _" "pharmaceutical companies , like _" "_ received U.S. Food" "plates were obtained from _" "multinationals such as _" "honoraria from _" "reagent was purchased from _" "_ 's new vaccine" "commercialization agreement with _" "acid were obtained from _" "PR rep from _" "Several other companies , including _" "chemicals division of _" "_ violated state consumer protection laws" "medicinal chemistry at _" "Spread Betting , updated DD-Dec-DD _" "Stock Ratings information for _" "venture equally owned by _" "_ did not inform consumers" "_ ends development" "_ is a global research-driven pharmaceutical company" "_ obtained FDA approval" "trial sponsored by _" "unrestricted educational grant by _" "multi-nationals such as _" "drug sold by _" "safety monitoring board for _" "_ obtained an exclusive license" "priority review to _" "generics business of _" "flows generated by _" "global corporations such as _" "commercial positions at _" "chemicals were purchased from _" "pills made by _" "pharmaceutical representative with _" "chemicals were obtained from _" "clinical study sponsored by _" "pharmaceutical company called _" "_ designed the trial" "honorarium from _" "research support from _" "sales last year for _" "application note from _" "potential cases against _" "CCC trend at _" "_ 's Canadian headquarters" "Chemistry sponsored by _" "_ 's Januvia" "senior research positions at _" "_ has asked the FDA" "pharmaceutical firms , including _" "speaker fees from _" "speaker honoraria from _" "engineering positions at _" "injury lawsuits against _" "_ 's antifungal" "Drug companies like _" "_ 's new drug" "pharmaceutical companies like _" "warning letter sent to _" "_ registered trade name" "big pharmaceutical companies like _" "_ secure personal information" "product liability lawsuits against _" "_ 's Vytorin" "_ launched a trial" "_ is conducting this recall" "_ is a large pharmaceutical company" "drug discovery efforts at _" "drug makers like _" "_ 's Packaging" "_ 's animal health division" "drug discovery collaboration with _" "solvents were purchased from _" "educational grant by _" "Dividend Stock Ratings information for _" "_ 's HIV vaccine" "_ 's Canadian affiliate" "_ transferred a part" "analysis were purchased from _" "_ sponsored the dinner" "reagents were purchased from _" "speakersbureau for _" "_ stopped selling in" "_ gets FDA OK" "drug developed by _" "corporate medical director for _" "_ has worldwide rights" "_ 's vaccine candidate" "vaccine division of _" "vaccine is manufactured by _" "major pharmaceutical companies including _" "American company like _" "CCC figure for _" "_ 's equity research report" "Pravachol , made by _" "Drug Administration asked _" "_ faces lawsuits" "_ stopped making the drug" "loss treatment from _" "medication you purchase is manufactured by _" "pharmaceutical research at _" "chemicals were from _" "company now owned by _" "co-marketing agreement with _" "compounds were obtained from _" "solution was obtained from _" "_ added the warning" "milestone payment from _" "lawsuits are being filed against _" "_ manufactured drug" "clinical trial sponsored by _" "lecture fees from _" "large firms such as _" "patent held by _" "protection business of _" "pharmaceutical sales representative with _" "_ 's generics business" "co-development agreement with _" "_ announced the FDA" "_ informed the agency" "_ submitted an NDA" "_ immediately cease the dissemination" "_ is the only pharmaceutical company" "research chemist at _" "pharma companies such as _" "multinational corporations such as _" "transnational corporations such as _" "independent educational grant from _" "vaccine is being developed by _" "_ recalled the drug" "pharmaceutical firms including _" "_ 's blockbuster drug" "_ has also acquired the rights" "_ denied these claims" "other reagents were obtained from _" "other corporations such as _" "large multinationals like _" "chemical companies like _" "drug is manufactured by _" "US companies including _" "collaboration agreement with _" "_ 's pharmaceutical sales" "_ 's research operations" "_ pulled the drug" "domestic companies like _" "consulting clients have included _" "pharma giant _" "pharmaceutical manufacturers , including _" "_ holds the patent" "national corporations including _" "major pharmaceutical companies , including _" "Pharmaceutical companies such as _" "_ 's investor relations team" "IAMC Active member with _" "_ 's 'DDD patent" "Major manufacturers such as _" "Products division of _" "medication made by _" "turn was acquired by _" "legitimate companies like _" "reagents were obtained from _" "such renowned names as _" "several pharmaceutical companies , including _" "share offer from _" "biotechnology companies , such as _" "_ submitted a Biologics License Application" "_ 's GENERIC DRUG" "senior research chemist at _" "_ is seeking FDA approval" "_ 's voluntary recall" "reagents were from _" "_ 's R&D pipeline" "_ 's Executive VP" "Vioxx , made by _" "lower-cost hedged play for _" "clinical development at _" "development areas at _" "_ has faced numerous lawsuits" "pharmaceutical representative for _" "pharmaceutical firms like _" "pharmaceutical sales representative for _" "plates were purchased from _" "trial was supported by _" "vaccine manufactured by _" "drug companies including _" "drug , manufactured by _" "drug is made by _" "independent grant from _" "medicine made by _" "FDA also required _" "_ 's Zocor" "Japanese subsidiary of _" "main competitors inc" ] using merck
• Seed
• company(100.0%)
• SEAL @23 (56.1%) on 19-jan-2010 [ 1 2 ] using merck___co
• MBL @1116 (99.8%) on 12-sep-2018 [ Promotion of biotechcompany:merck headquarteredin city:whitehouse_station ] using concept:biotechcompany:merck
• OE @962 (100.0%) on 05-dec-2015 [ http://www.studymode.com/essays/Merck-And-Co-River-Blindness-846240.html http://www.cbsnews.com/news/new-drug-offers-promise-cure-hepatitis-c/ http://www.studymode.com/essays/Merck-And-Co-River-Blindness-846240.html http://www.studymode.com/essays/Merck-And-Co-River-Blindness-846240.html  ] using merck_and_co
• SEAL @623 (66.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ] using merck_and_co
• CMC @1079 (100.0%) on 24-sep-2017 [ LAST_WORD=co 3.21851 PREFIX=mer 2.29469 PREFIX=merc 1.67262 SUFFIX=erck 1.19303 SUFFIX=rck 1.06700 FIRST_WORD=merck 1.06245 FULL_POS=NN_CC_NN 0.94279 CHARS -0.55834 WORDS -0.93039 SHORT_WORDSHAPE=a -1.92772 ] using merck_and_co
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of ceo:richard_clark ceoof biotechcompany:merck ] using concept:ceo:richard_clark
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of person:raymond_gilmartin topmemberoforganization biotechcompany:merck ] using concept:person:raymond_gilmartin
• CMC @1116 (100.0%) on 05-sep-2018 [ LAST_WORD=co 5.02759 PREFIX=mer 1.43024 SUFFIX=rck 1.24467 SUFFIX=erck 1.23315 PREFIX=merc 1.21548 WORDSHAPE=x 1.10786 POS=CC 0.74531 CHARS -0.43540 SHORT_WORDSHAPE=a -0.43720 WORDS -1.32422 ] using merck___co
• SEAL @34 (76.7%) on 26-jan-2010 [ 1 2 3 ] using merck
• humanagent(100.0%)
• Seed
• Human feedback from bkisiel @918 on 13-apr-2015 [ "enalapril drugworkedonbyagent merck", Action=(+drugworkedonbyagent) (from NELL.08m.924.SSFeedback.csv) ] using merck

NELL has only weak evidence for items listed in grey

• website
• SEAL @334 (50.0%) on 04-jul-2011 [ 1 ] using merck

relations

• acquired
• schering_plough (99.2%)
• CPL @1094 (99.2%) on 01-jan-2018 [ "arg1 has acquired arg2" "arg1 completed its merger with arg2" "arg1 completes its acquisition of arg2" "arg1 acquired arg2" "arg1 announced its merger with arg2" "arg1 bought arg2" "arg1 is about to acquire arg2" ] using (merck, schering_plough)
• agentcollaborateswithagent
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• OE @838 (100.0%) on 16-may-2014 [ http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.ahrp.org/infomail/05/05/06a.php http://pharmagossip.blogspot.com/2006/01/merck-vioxx-call-raymond-gilmartin.html http://intuitive.com/merck_ceo_raymond_gilmartin_sees_14_mil_bonus_for_2004.html  ] using (raymond_gilmartin, merck)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (merck, raymond_gilmartin)
• OE @838 (100.0%) on 16-may-2014 [ http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.ahrp.org/infomail/05/05/06a.php http://pharmagossip.blogspot.com/2006/01/merck-vioxx-call-raymond-gilmartin.html http://intuitive.com/merck_ceo_raymond_gilmartin_sees_14_mil_bonus_for_2004.html  ] using (merck, raymond_gilmartin)
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• OE @838 (100.0%) on 16-may-2014 [ http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.ahrp.org/infomail/05/05/06a.php http://pharmagossip.blogspot.com/2006/01/merck-vioxx-call-raymond-gilmartin.html http://intuitive.com/merck_ceo_raymond_gilmartin_sees_14_mil_bonus_for_2004.html  ] using (raymond_gilmartin, merck)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (merck, raymond_gilmartin)
• OE @838 (100.0%) on 16-may-2014 [ http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.naturalnews.com/010613_Merck_Vioxx.html http://www.ahrp.org/infomail/05/05/06a.php http://pharmagossip.blogspot.com/2006/01/merck-vioxx-call-raymond-gilmartin.html http://intuitive.com/merck_ceo_raymond_gilmartin_sees_14_mil_bonus_for_2004.html  ] using (merck, raymond_gilmartin)
• richard_clark (ceo) (99.9%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (merck, richard_clark)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (richard_clark, merck)
• richard_clark (ceo) (99.9%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (merck, richard_clark)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (richard_clark, merck)
• agentcontrols
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 chairman arg2" "arg1 and its CEO arg2" "arg1 President and CEO arg2" "arg1 chief executive arg2" "arg1 chairman and chief executive officer arg2" "arg1 Chairman and CEO arg2" ] using (merck, raymond_gilmartin)
• OE @838 (100.0%) on 16-may-2014 [ http://www.naturalnews.com/010613_Merck_Vioxx.html http://intuitive.com/merck_ceo_raymond_gilmartin_sees_14_mil_bonus_for_2004.html http://www.naturalnews.com/010613_Merck_Vioxx.html http://pharmagossip.blogspot.com/2006/01/merck-vioxx-call-raymond-gilmartin.html http://www.ahrp.org/infomail/05/05/06a.php  ] using (merck, raymond_gilmartin)
• richard_clark (ceo) (96.9%)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman arg2" "arg1 chief executive arg2" "arg1 president and CEO arg2" "arg1 CEO and president arg2" "arg1 President and CEO arg2" ] using (merck, richard_clark)
• agentcreated
• enalapril (chemical) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, enalapril)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, enalapril)
• cancidas (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, cancidas)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, cancidas)
• caspofungin (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, caspofungin)
• OE @1012 (100.0%) on 17-aug-2016 [ http://jcm.asm.org/content/47/12/4043.full http://www.bioline.org.br/request?ph10003  ] using (merck_and_co, caspofungin)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, caspofungin)
• crixivan (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, crixivan)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, crixivan)
• dichlorphenamide (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, dichlorphenamide)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, dichlorphenamide)
• emend (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, emend)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, emend)
• ertapenem (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, ertapenem)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, ertapenem)
• famotidine (drug) (100.0%)
• OE @1003 (100.0%) on 01-jul-2016 [ http://www.slideshare.net/sridharsri5661/formulation-and-evaluation-of-fast-dissolving-tablet-by-aryan-and-rajesh  ] using (merck_and_co, famotidine)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, famotidine)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, famotidine)
• fosamax (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, fosamax)
• OE @985 (100.0%) on 17-mar-2016 [ http://www.huffingtonpost.com/martha-rosenberg/are-you-taking-pills-you-_b_920990.html  ] using (merck_and_co, fosamax)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, fosamax)
• hyzaar (100.0%)
• OE @1018 (100.0%) on 01-oct-2016 [ http://www.fiercepharma.com/special-report/cozaar-hyzaar-big-patent-expirations-of-2010 https://en.wikipedia.org/wiki/Losartan/hydrochlorothiazide  ] using (merck, hyzaar)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, hyzaar)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, hyzaar)
• indinavir (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, indinavir)
• OE @1012 (91.9%) on 17-aug-2016 [ http://aac.asm.org/content/44/4/1029.full http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://europepmc.org/articles/PMC3111241 http://jvi.asm.org/content/73/10/8813.full  ] using (merck_and_co, indinavir)
• OE @1012 (85.5%) on 17-aug-2016 [ http://www.aidsmap.com/resources/treatmentsdirectory/drugs/Indinavir-iCrixivani/page/1731064/ http://www.drugdevelopment-technology.com/projects/indinavir-inhibitor/ http://www.drugdevelopment-technology.com/projects/indinavir-inhibitor/ http://www.ncbi.nlm.nih.gov/pubmed/11363299 http://www.nytimes.com/1996/01/30/science/3-drug-therapy-shows-promise-against-aids.html http://www.aidsinfonet.org/fact_sheets/view/441  ] using (merck, indinavir)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, indinavir)
• indinavir_sulfate (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, indinavir_sulfate)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, indinavir_sulfate)
• intron_a (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, intron_a)
• OE @1012 (95.0%) on 17-aug-2016 [ http://www.rotlaw.com/intron-a/ http://www.merckaccessprogram.com/hcp/intron-a/ http://oncpracticemanagement.com/pssguide2016/merck-helps/ http://oncpracticemanagement.com/pssguide2016/merck-helps/ http://www.merckaccessprogram.com/hcp/intron-a/ http://oncpracticemanagement.com/pssguide2016/merck-helps/  ] using (merck, intron_a)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, intron_a)
• januvia (drug) (100.0%)
• OE @1012 (92.3%) on 17-aug-2016 [ http://www.bloomberg.com/news/articles/2015-09-16/merck-s-once-weekly-diabetes-pill-is-as-good-as-januvia-in-study http://www.mercknewsroom.com/news-release/prescription-medicine-news/tecos-mercks-cardiovascular-safety-trial-januvia-sitagliptin http://www.bloomberg.com/news/articles/2015-08-21/merck-s-diabetes-dominance-at-risk-as-rival-drug-helps-out-heart http://www.mercknewsroom.com/news-release/prescription-medicine-news/merck-announces-trial-evaluating-cardiovascular-outcomes-sit http://www.mercknewsroom.com/news-release/prescription-medicine-news/tecos-mercks-cardiovascular-safety-trial-januvia-sitagliptin http://www.mercknewsroom.com/news-release/prescription-medicine-news/tecos-mercks-cardiovascular-safety-trial-januvia-sitagliptin http://www.fiercepharma.com/pharma/januvia-holds-off-sglt2s-to-keep-merck-s-q2-line http://www.bloomberg.com/news/articles/2015-08-21/merck-s-diabetes-dominance-at-risk-as-rival-drug-helps-out-heart http://www.bloomberg.com/news/articles/2015-09-16/merck-s-once-weekly-diabetes-pill-is-as-good-as-januvia-in-study  ] using (merck, januvia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, januvia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, januvia)
• OE @964 (100.0%) on 13-dec-2015 [ http://injurylawyer-news.com/category/januvia-byetta/  ] using (merck_and_co, januvia)
• losartan (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, losartan)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, losartan)
• norfloxacin (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, norfloxacin)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, norfloxacin)
• pegintron (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, pegintron)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, pegintron)
• propecia (100.0%)
• OE @1033 (97.1%) on 25-dec-2016 [ http://drugreporter.com/2015/01/propecia-side-effects-persist-according-new-lawsuit/ http://proscarpropecia.com/ http://www.hda-online.org.uk/hair-loss/propecia/how-was-propecia-discovered.html http://www.pillwatch.com/info/rogaine-vs-propecia.html http://proscarpropecia.com/ http://www.hairline.ge/en/hair-loss-treatment http://atlanta.legalexaminer.com/fda-prescription-drugs/propecia-still-being-given-despite-the-known-risks/ http://www.tobuypropecia.com/Comparisons.html  ] using (merck_and_co, propecia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, propecia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, propecia)
• proscar (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, proscar)
• OE @1003 (100.0%) on 01-jul-2016 [ http://abcnews.go.com/Health/MensHealth/baldness-drug-sexual-effects/story?id=13152993  ] using (merck_and_co, proscar)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, proscar)
• singulair (100.0%)
• OE @1012 (98.9%) on 17-aug-2016 [ http://www.fiercepharma.com/sales-and-marketing/merck-proposal-to-sell-singulair-without-a-prescription-hits-resistance http://www.marketwatch.com/story/merck-profit-down-35-as-singulair-sales-fall-2013-10-28 http://www.pmlive.com/top_pharma_list/pharmaceutical_products/singulair http://www.pmlive.com/top_pharma_list/pharmaceutical_products/singulair http://www.wsj.com/articles/SB10001424127887324766604578456500458857418 http://www.fiercepharma.com/sales-and-marketing/merck-proposal-to-sell-singulair-without-a-prescription-hits-resistance https://en.wikipedia.org/wiki/Montelukast http://www.wsj.com/articles/SB10001424127887324766604578456500458857418 http://www.cbsnews.com/news/is-mercks-singulair-patent-a-fraud-suit-lays-out-timeline-of-omissions/ http://www.cbsnews.com/news/is-mercks-singulair-patent-a-fraud-suit-lays-out-timeline-of-omissions/ https://en.wikipedia.org/wiki/Montelukast http://www.fiercepharma.com/sales-and-marketing/merck-proposal-to-sell-singulair-without-a-prescription-hits-resistance http://www.cbsnews.com/news/is-mercks-singulair-patent-a-fraud-suit-lays-out-timeline-of-omissions/ http://www.cbsnews.com/news/is-mercks-singulair-patent-a-fraud-suit-lays-out-timeline-of-omissions/  ] using (merck, singulair)
• OE @964 (100.0%) on 13-dec-2015 [ http://www.princetonallergy.com/singulair.php  ] using (merck_and_co, singulair)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, singulair)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, singulair)
• temodar (drug) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, temodar)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, temodar)
• OE @1003 (100.0%) on 01-jul-2016 [ http://www.parentherald.com/articles/26337/20160308/celldex-therapeutics-abandoned-study-brain-cancer-vaccine-rintega.htm  ] using (merck_and_co, temodar)
• timolide (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, timolide)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, timolide)
• zocor (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, zocor)
• OE @985 (100.0%) on 17-mar-2016 [ http://www.statinanswers.com/types.htm https://www.lawyersandsettlements.com/articles/zocor/zocor-side-effects-simvastatin-5-16793.html  ] using (merck_and_co, zocor)
• OE @1012 (92.0%) on 17-aug-2016 [ https://www.lawyersandsettlements.com/lawsuit/zocor.html http://www.washingtonpost.com/wp-dyn/content/article/2006/06/22/AR2006062201827.html http://www.washingtonpost.com/wp-dyn/content/article/2006/06/22/AR2006062201827.html https://www.justice.gov/archive/opa/pr/2008/February/08_civ_094.html http://www.fiercepharma.com/regulatory/advera-health-analytics-merck-statins-linked-to-more-muscle-side-effects-than-rest-of http://www.washingtonpost.com/wp-dyn/content/article/2006/06/22/AR2006062201827.html http://money.cnn.com/2006/06/15/news/companies/zoloft_zocor/ http://money.cnn.com/2006/06/15/news/companies/zoloft_zocor/ http://www.internetlibrary.com/cases/lib_case421.cfm http://www.wikinvest.com/stock/Merck_(MRK) http://www.washingtonpost.com/wp-dyn/content/article/2006/06/22/AR2006062201827.html http://money.cnn.com/2006/06/15/news/companies/zoloft_zocor/ http://www.washingtonpost.com/wp-dyn/content/article/2008/02/07/AR2008020701336.html https://en.wikipedia.org/wiki/Simvastatin http://www.internetlibrary.com/cases/lib_case421.cfm  ] using (merck, zocor)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, zocor)
• agentworkedondrug
• caspofungin (drug) (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (caspofungin, merck)
• OE @826 (100.0%) on 28-mar-2014 [   ] using (caspofungin, merck)
• dichlorphenamide (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (dichlorphenamide, merck)
• OE @802 (100.0%) on 09-jan-2014 [  ] using (dichlorphenamide, merck)
• enalapril (drug) (100.0%)
• OE @1012 (100.0%) on 17-aug-2016 [ http://blood-pressure.emedtv.com/enalapril/generic-enalapril.html http://caselaw.findlaw.com/us-federal-circuit/1144342.html http://ipkitten.blogspot.com/2007/09/national-courts-can-apply-trips-and.html http://ipkitten.blogspot.com/2007/09/national-courts-can-apply-trips-and.html http://www.healio.com/endocrinology/diabetes/news/print/endocrine-today/%7Be323cca9-f956-4618-920a-bec48a16aad7%7D/enalapril-losartan-treatment-delayed-progression-of-retinopathy-in-patients-with-type-1-diabetes http://caselaw.findlaw.com/us-federal-circuit/1144342.html  ] using (enalapril, merck)
• Human feedback from bkisiel @918 on 13-apr-2015 [ "enalapril drugworkedonbyagent merck", Action=(+drugworkedonbyagent) (from NELL.08m.924.SSFeedback.csv) ] using (enalapril, merck)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (enalapril, merck)
• ertapenem (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (ertapenem, merck)
• OE @802 (91.2%) on 09-jan-2014 [   ] using (ertapenem, merck)
• famotidine (drug) (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (famotidine, merck)
• OE @806 (100.0%) on 23-jan-2014 [   ] using (famotidine, merck)
• indinavir (100.0%)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 is marketed by arg2" ] using (indinavir, merck)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (indinavir, merck)
• OE @838 (100.0%) on 16-may-2014 [ http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://www.ncbi.nlm.nih.gov/pubmed/10651394 http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://journals.lww.com/aidsonline/fulltext/1998/11000/indinavir_pharmacokinetics_in.25.aspx http://en.wikipedia.org/wiki/Indinavir  ] using (indinavir, merck)
• indinavir_sulfate (100.0%)
• Seed
• SEAL @664 (50.0%) on 27-nov-2012 [ 1 2 3 ] using (indinavir_sulfate, merck)
• januvia (drug) (100.0%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (januvia, merck)
• SEAL @221 (50.0%) on 18-mar-2011 [ 1 ] using (januvia, merck___co)
• SEAL @298 (100.0%) on 14-jun-2011 [ 1 ] using (januvia, merck)
• lisinopril (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (lisinopril, merck)
• OE @1087 (93.2%) on 20-dec-2017 [ http://reports.fja.gc.ca/eng/2007/2006fca323.html http://en.wikipedia.org/wiki/Lisinopril http://reports.fja.gc.ca/eng/2007/2006fca323.html http://reports.fja.gc.ca/eng/2007/2006fca323.html http://reports.fja.gc.ca/eng/2007/2006fca323.html http://reports.fja.gc.ca/eng/2007/2006fca323.html  ] using (lisinopril, merck)
• losartan (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (losartan, merck)
• OE @1087 (100.0%) on 20-dec-2017 [ http://en.wikipedia.org/wiki/Losartan  ] using (losartan, merck)
• norfloxacin (drug) (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (norfloxacin, merck)
• OE @809 (91.8%) on 01-feb-2014 [   ] using (norfloxacin, merck)
• timolide (100.0%)
• SEAL @236 (100.0%) on 16-apr-2011 [ 1 ] using (timolide, merck)
• vioxx (100.0%)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 is manufactured by arg2" ] using (vioxx, merck___co)
• CPL @1094 (100.0%) on 01-jan-2018 [ "arg2 faces over arg1" "arg2 marketed and promoted arg1" "arg2 illegally promoted arg1" "arg2 Arthritis drug arg1" "arg2 to halt sales of arg1" "arg2 refuses to settle arg1" "arg2 to add a warning to arg1" "arg2 to relabel arg1" "arg2 began marketing arg1" "arg2 unexpectedly lost arg1" "arg2 heavily promoted arg1" "arg2 has continued to maintain arg1" "arg2 kept selling arg1" "arg2 aggressively promoted arg1" "arg2 had to make with arg1" "arg2 voluntarily removed arg1" "arg2 knew about the dangers of arg1" "arg2 received FDA approval for arg1" "arg2 eventually did test arg1" "arg2 knew of the risks of arg1" "arg2 showed that patients taking arg1" "arg2 continued to market arg1" "arg2 was forced to withdraw arg1" "arg2 over its painkiller arg1" "arg2 eventually pulled arg1" "arg2 is the manufacturer of arg1" "arg2 suddenly pulled arg1" "arg2 voluntarily pulled arg1" "arg2 aggressively marketed arg1" "arg2 had marketed arg1" "arg2 arthritis drug arg1" "arg2 knew of the dangers of arg1" "arg2 regarding its product arg1" "arg2 the maker of arg1" "arg2 last December on arg1" "arg2 knew the risks of arg1" "arg2 announced it was pulling arg1" "arg2 downplayed the risks of arg1" "arg2 has voluntarily withdrawn arg1" "arg2 NDA for arg1" "arg2 voluntarily withdrew arg1" "arg2 to go on trial arg1" ] using (vioxx, merck)
• SEAL @224 (93.8%) on 24-mar-2011 [ 1 2 3 4 ] using (vioxx, merck)
• fosamax (drug) (100.0%)
• SEAL @221 (50.0%) on 18-mar-2011 [ 1 ] using (fosamax, merck___co)
• SEAL @241 (96.9%) on 22-apr-2011 [ 1 2 3 4 5 ] using (fosamax, merck)
• CPL @1094 (99.8%) on 01-jan-2018 [ "arg2 to add a warning to arg1" "arg2 about my problems with arg1" "arg2 is the manufacturer of arg1" "arg2 the maker of arg1" "arg2 aggressively promoted arg1" "arg2 failed to adequately research arg1" "arg2 EVISTA has arg1" "arg2 FOSAMAX has arg1" "arg2 has continued to market arg1" ] using (fosamax, merck)
• zocor (100.0%)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 under the trade name arg1" ] using (zocor, merck___co)
• SEAL @221 (50.0%) on 18-mar-2011 [ 1 ] using (zocor, merck___co)
• OE @823 (98.1%) on 17-mar-2014 [   ] using (zocor, merck)
• CPL @1095 (50.0%) on 17-jan-2018 [ "arg1 is marketed by arg2" ] using (zocor, merck)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (zocor, merck)
• emend (drug) (99.2%)
• SEAL @224 (96.9%) on 24-mar-2011 [ 1 2 3 4 5 ] using (emend, merck)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 also markets arg1" ] using (emend, merck)
• singulair (98.4%)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (singulair, merck)
• SEAL @221 (50.0%) on 18-mar-2011 [ 1 ] using (singulair, merck___co)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 manufactured by arg2" "arg1 was originally developed by arg2" ] using (singulair, merck)
• cancidas (96.9%)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (cancidas, merck)
• SEAL @224 (93.8%) on 24-mar-2011 [ 1 2 3 4 ] using (cancidas, merck)
• hyzaar (96.9%)
• CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 is manufactured by arg2" ] using (hyzaar, merck)
• SEAL @241 (93.8%) on 22-apr-2011 [ 1 2 3 4 ] using (hyzaar, merck)
• intron_a (96.9%)
• SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (intron_a, merck)
• odanacatib (96.9%)
• SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (odanacatib, merck)
• pegintron (drug) (96.9%)
• SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (pegintron, merck)
• proscar (96.9%)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (proscar, merck)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 claims that less than arg1" ] using (proscar, merck)
• temodar (drug) (96.9%)
• SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (temodar, merck)
• crixivan (93.8%)
• SEAL @305 (93.8%) on 19-jun-2011 [ 1 2 3 4 ] using (crixivan, merck)
• maxalt (93.8%)
• SEAL @221 (50.0%) on 18-mar-2011 [ 1 ] using (maxalt, merck___co)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (maxalt, merck)
• propecia (93.8%)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 lawsuits allege that arg2" "arg1 is manufactured by arg2" "arg1 lawsuits filed against arg2" ] using (propecia, merck)
• SEAL @548 (50.0%) on 06-apr-2012 [ 1 ] using (propecia, merck)
• companyceo
• richard_clark (ceo) (100.0%)
• SEAL @592 (75.0%) on 12-jun-2012 [ 1 2 ] using (richard_t__clark, merck)
• OE @877 (100.0%) on 09-oct-2014 [ http://www.dailyfinance.com/2010/11/30/merck-kenneth-frazier-ceo/ http://www.csrwire.com/press_releases/34376-Merck-Launches-Richard-T-Clark-Fellowship-Program-with-PSI-Partnership  ] using (richard_clark, merck)
• CPL @1094 (99.2%) on 01-jan-2018 [ "arg2 chief arg1" "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" "arg2 Chief Executive Officer and President arg1" ] using (richard_clark, merck)
• SEAL @214 (50.0%) on 22-feb-2011 [ 1 ] using (richard_clark, merck)
• controlledbyagent
• raymond_gilmartin (93.8%)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• hasofficeincity
• whitehouse_station (city) (100.0%)
• SEAL @25 (50.0%) on 20-jan-2010 [ 1 ] using (merck, whitehouse_station)
• SEAL @382 (50.0%) on 10-aug-2011 [ 1 ] using (merck___co, whitehouse_station)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg1 and Company of arg2" "arg1 Headquarters in arg2" "arg1 Research Laboratories in arg2" "arg1 global headquarters in arg2" ] using (merck, whitehouse_station)
• OE @997 (99.7%) on 27-may-2016 [ http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.mercknewsroom.com/news-release/corporate-news/merck-updates-plans-headquarters-move-new-jersey http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html  ] using (merck, whitehouse_station)
• headquarteredin
• whitehouse_station (city) (99.8%)
• OE @992 (92.0%) on 27-apr-2016 [ http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.mercknewsroom.com/news-release/corporate-news/merck-updates-plans-headquarters-move-new-jersey http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html  ] using (merck, whitehouse_station)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 and Company of arg2" "arg1 Pharmaceuticals in arg2" "arg1 global headquarters in arg2" ] using (merck, whitehouse_station)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (merck, whitehouse_station)
• organizationhasagent
• richard_clark (ceo) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:agentcollaborateswithagent,concept:agentinteractswithagent" "Y~X0~concept:agentcontrols,concept:agentinteractswithagent,concept:agentinteractswithagent" "Y~X0~concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyperson,concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyagent,concept:proxyfor" ] using (richard_clark, merck)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (richard_clark, merck)
• OE @964 (100.0%) on 13-dec-2015 [ http://www.dailyfinance.com/2010/11/30/merck-kenneth-frazier-ceo/ http://www.csrwire.com/press_releases/34376-Merck-Launches-Richard-T-Clark-Fellowship-Program-with-PSI-Partnership http://abcnews.go.com/topics/business/CEOs/richard-clark.htm http://abcnews.go.com/topics/business/CEOs/richard-clark.htm  ] using (richard_clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:agentcollaborateswithagent,concept:agentinteractswithagent" "Y~X0~concept:agentcontrols,concept:agentinteractswithagent,concept:agentinteractswithagent" "Y~X0~concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyperson,concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyagent,concept:proxyfor" ] using (richard_t__clark, merck_and_co)
• OE @973 (88.5%) on 23-jan-2016 [ http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.projecthope.org/news-blogs/press-releases/2011/project-hope-welcomes-merck.html https://en.wikipedia.org/wiki/Richard_Clark_(pharmacologist) http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- https://www.youtube.com/watch?v=flCTVqnpjzM http://pyxeraglobal.org/partners/private/merck/ http://articles.philly.com/2005-05-06/business/25440629_1_merck-manufacturing-division-richard-t-clark-whitehouse-station http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://pyxeraglobal.org/partners/private/merck/ http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://pyxeraglobal.org/partners/private/merck/  ] using (richard_t__clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:agentcollaborateswithagent,concept:agentinteractswithagent" "Y~X0~concept:agentcontrols,concept:agentinteractswithagent,concept:agentinteractswithagent" "Y~X0~concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyperson,concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyagent,concept:proxyfor" ] using (richard_t__clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:agentcollaborateswithagent,concept:agentinteractswithagent" "Y~X0~concept:agentcontrols,concept:agentinteractswithagent,concept:agentinteractswithagent" "Y~X0~concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyperson,concept:proxyfor" "Y~X0~concept:proxyfor,concept:organizationleadbyagent,concept:proxyfor" ] using (richard_clark, merck_and_co)
• OE @1000 (100.0%) on 09-jun-2016 [ https://en.wikipedia.org/wiki/Business_war_games http://bizshifts-trends.com/2011/03/14/%E2%80%9Cbusiness-war-gaming%E2%80%9D-key-to-winning-business-strategies-%E2%80%93-is-it-the-future/ https://es.wikipedia.org/wiki/Juegos_de_guerra_en_negocios  ] using (richard_clark, merck_and_co)
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• OE @980 (100.0%) on 21-feb-2016 [ http://www.jyi.org/issue/interview-with-raymond-gilmartin-former-ceo-of-merck-co-inc/ http://www.businessweek.com/management/merck-gilmartin-vioxxand-drucker-10072011.html http://www.nbcnews.com/id/6472384/ns/nbc_nightly_news_with_brian_williams/t/ceo-defends-merck-vioxx-heart-dangers/ http://www.allgov.com/news/top-stories/ceo-who-oversaw-mass-vioxx-deaths-now-teaching-at-harvard-and-on-microsoft-board-of-directors?news=844479  ] using (raymond_gilmartin, merck)
• organizationhasperson
• richard_clark (ceo) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentcontrols" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentcontrols" ] using (richard_clark, merck)
• OE @973 (85.6%) on 23-jan-2016 [ http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.projecthope.org/news-blogs/press-releases/2011/project-hope-welcomes-merck.html https://en.wikipedia.org/wiki/Richard_Clark_(pharmacologist) https://www.youtube.com/watch?v=flCTVqnpjzM http://pyxeraglobal.org/partners/private/merck/ http://articles.philly.com/2005-05-06/business/25440629_1_merck-manufacturing-division-richard-t-clark-whitehouse-station http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://pyxeraglobal.org/partners/private/merck/ http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://pyxeraglobal.org/partners/private/merck/  ] using (richard_t__clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentcontrols" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentcontrols" ] using (richard_t__clark, merck)
• CPL @1095 (96.9%) on 17-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (richard_clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentcontrols" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentcontrols" ] using (richard_clark, merck_and_co)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:organizationhasperson,concept:agentcontrols" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentcontrols" ] using (richard_t__clark, merck_and_co)
• OE @964 (100.0%) on 13-dec-2015 [ http://abcnews.go.com/topics/business/CEOs/richard-clark.htm http://abcnews.go.com/topics/business/CEOs/richard-clark.htm http://www.dailyfinance.com/2010/11/30/merck-kenneth-frazier-ceo/ http://www.csrwire.com/press_releases/34376-Merck-Launches-Richard-T-Clark-Fellowship-Program-with-PSI-Partnership  ] using (richard_clark, merck)
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentcontrols" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" ] using (raymond_gilmartin, merck)
• OE @838 (87.1%) on 16-may-2014 [ http://www.nbcnews.com/id/6472384/ns/nbc_nightly_news_with_brian_williams/t/ceo-defends-merck-vioxx-heart-dangers/ http://www.jyi.org/issue/interview-with-raymond-gilmartin-former-ceo-of-merck-co-inc/ http://www.allgov.com/news/top-stories/ceo-who-oversaw-mass-vioxx-deaths-now-teaching-at-harvard-and-on-microsoft-board-of-directors?news=844479 http://www.businessweek.com/management/merck-gilmartin-vioxxand-drucker-10072011.html  ] using (raymond_gilmartin, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentcontrols" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" ] using (raymond_gilmartin, merck_and_co)
• OE @961 (100.0%) on 24-nov-2015 [ http://www.abc.net.au/4corners/content/2005/s1341036.htm  ] using (raymond_gilmartin, merck_and_co)
• organizationhastopmember
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• OE @838 (100.0%) on 16-may-2014 [ http://www.jyi.org/issue/interview-with-raymond-gilmartin-former-ceo-of-merck-co-inc/ http://www.nbcnews.com/id/6472384/ns/nbc_nightly_news_with_brian_williams/t/ceo-defends-merck-vioxx-heart-dangers/ http://www.businessweek.com/management/merck-gilmartin-vioxxand-drucker-10072011.html http://www.allgov.com/news/top-stories/ceo-who-oversaw-mass-vioxx-deaths-now-teaching-at-harvard-and-on-microsoft-board-of-directors?news=844479  ] using (raymond_gilmartin, merck)
• richard_clark (ceo) (98.4%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" "arg2 Chief Executive Officer and President arg1" ] using (richard_clark, merck)
• organizationhiredperson
• richard_clark (ceo) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:organizationleadbyperson" "Y~_X0~concept:organizationrepresentedbyagent" "Y~_X0~concept:organizationleadbyagent" "Y~_X0~concept:controlledbyagent" "Y~_X0~concept:proxyof" ] using (merck, richard_clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:organizationleadbyperson" "Y~_X0~concept:organizationrepresentedbyagent" "Y~_X0~concept:organizationleadbyagent" "Y~_X0~concept:controlledbyagent" "Y~_X0~concept:proxyof" ] using (merck_and_co, richard_clark)
• organizationleadbyperson
• richard_clark (ceo) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (richard_clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (richard_t__clark, merck)
• OE @806 (100.0%) on 23-jan-2014 [   ] using (richard_clark, merck)
• SEAL @526 (75.0%) on 07-mar-2012 [ 1 2 ] using (richard_t__clark, merck)
• OE @965 (91.2%) on 17-dec-2015 [ http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://articles.philly.com/2005-05-06/business/25440629_1_merck-manufacturing-division-richard-t-clark-whitehouse-station http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://pyxeraglobal.org/partners/private/merck/ https://en.wikipedia.org/wiki/Richard_Clark_(pharmacologist) https://www.youtube.com/watch?v=flCTVqnpjzM http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://pyxeraglobal.org/partners/private/merck/ http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://pyxeraglobal.org/partners/private/merck/ http://www.projecthope.org/news-blogs/press-releases/2011/project-hope-welcomes-merck.html http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa  ] using (richard_t__clark, merck)
• SEAL @302 (100.0%) on 18-jun-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ] using (richard_clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (richard_clark, merck_and_co)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (richard_t__clark, merck_and_co)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" "arg2 Chief Executive Officer and President arg1" ] using (richard_clark, merck)
• OE @964 (100.0%) on 13-dec-2015 [ https://en.wikipedia.org/wiki/Business_war_games https://es.wikipedia.org/wiki/Juegos_de_guerra_en_negocios http://bizshifts-trends.com/2011/03/14/%E2%80%9Cbusiness-war-gaming%E2%80%9D-key-to-winning-business-strategies-%E2%80%93-is-it-the-future/  ] using (richard_clark, merck_and_co)
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• OE @838 (100.0%) on 16-may-2014 [ http://www.jyi.org/issue/interview-with-raymond-gilmartin-former-ceo-of-merck-co-inc/ http://www.allgov.com/news/top-stories/ceo-who-oversaw-mass-vioxx-deaths-now-teaching-at-harvard-and-on-microsoft-board-of-directors?news=844479 http://www.nbcnews.com/id/6472384/ns/nbc_nightly_news_with_brian_williams/t/ceo-defends-merck-vioxx-heart-dangers/ http://www.businessweek.com/management/merck-gilmartin-vioxxand-drucker-10072011.html  ] using (raymond_gilmartin, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (raymond_gilmartin, merck)
• OE @985 (100.0%) on 17-mar-2016 [ http://www.abc.net.au/4corners/content/2005/s1341036.htm  ] using (raymond_gilmartin, merck_and_co)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (raymond_gilmartin, merck_and_co)
• organizationterminatedperson
• richard_clark (ceo) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck, richard_t__clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck_and_co, richard_clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck_and_co, richard_t__clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck, richard_clark)
• raymond_gilmartin (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck_and_co, raymond_gilmartin)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck, raymond_gilmartin)
• proxyof
• raymond_gilmartin (93.8%)
• CPL @1096 (93.8%) on 18-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 chief executive arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• synonymfor
• zocor (93.8%)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, zocor)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 is a registered trademark of arg2" ] using (zocor, merck)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (zocor, merck___co)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (merck___co, zocor)
• zocor (93.8%)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, zocor)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 is a registered trademark of arg2" ] using (zocor, merck)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (zocor, merck___co)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (merck___co, zocor)
• worker
• richard_clark (ceo) (100.0%)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:worker,concept:agentleadsorganization" "Y~X0~concept:proxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" ] using (richard_clark, merck)
• CPL @1095 (98.4%) on 17-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" "arg2 Chief Executive Officer and President arg1" ] using (richard_clark, merck)
• OE @964 (100.0%) on 13-dec-2015 [ https://en.wikipedia.org/wiki/Business_war_games http://bizshifts-trends.com/2011/03/14/%E2%80%9Cbusiness-war-gaming%E2%80%9D-key-to-winning-business-strategies-%E2%80%93-is-it-the-future/ https://es.wikipedia.org/wiki/Juegos_de_guerra_en_negocios  ] using (richard_clark, merck_and_co)
• OE @964 (100.0%) on 13-dec-2015 [ http://www.dailyfinance.com/2010/11/30/merck-kenneth-frazier-ceo/ http://abcnews.go.com/topics/business/CEOs/richard-clark.htm http://abcnews.go.com/topics/business/CEOs/richard-clark.htm http://www.csrwire.com/press_releases/34376-Merck-Launches-Richard-T-Clark-Fellowship-Program-with-PSI-Partnership  ] using (richard_clark, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:worker,concept:agentleadsorganization" "Y~X0~concept:proxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" ] using (richard_clark, merck_and_co)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:worker,concept:agentleadsorganization" "Y~X0~concept:proxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" ] using (richard_t__clark, merck_and_co)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentcontrols,concept:worker,concept:agentleadsorganization" "Y~X0~concept:proxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:mutualproxyfor,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" ] using (richard_t__clark, merck)
• OE @965 (96.3%) on 17-dec-2015 [ http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- https://www.youtube.com/watch?v=flCTVqnpjzM https://en.wikipedia.org/wiki/Richard_Clark_(pharmacologist) http://articles.philly.com/2005-05-06/business/25440629_1_merck-manufacturing-division-richard-t-clark-whitehouse-station http://www.mercknewsroom.com/press-release/corporate-news/merck-board-elects-kenneth-c-frazier-next-ceo-richard-t-clark-continue- http://www.projecthope.org/news-blogs/press-releases/2011/project-hope-welcomes-merck.html http://pyxeraglobal.org/partners/private/merck/ http://pyxeraglobal.org/partners/private/merck/ http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa http://pyxeraglobal.org/partners/private/merck/ http://www.mercknewsroom.com/press-release/corporate-responsibility-news/merck-launches-richard-t-clark-fellowship-program-psi-pa  ] using (richard_t__clark, merck)
• raymond_gilmartin (100.0%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 and its CEO arg1" "arg2 President and CEO arg1" "arg2 chief executive arg1" "arg2 chairman and chief executive officer arg1" "arg2 Chairman and CEO arg1" ] using (raymond_gilmartin, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (raymond_gilmartin, merck_and_co)
• OE @838 (100.0%) on 16-may-2014 [ http://www.jyi.org/issue/interview-with-raymond-gilmartin-former-ceo-of-merck-co-inc/ http://www.nbcnews.com/id/6472384/ns/nbc_nightly_news_with_brian_williams/t/ceo-defends-merck-vioxx-heart-dangers/ http://www.allgov.com/news/top-stories/ceo-who-oversaw-mass-vioxx-deaths-now-teaching-at-harvard-and-on-microsoft-board-of-directors?news=844479  ] using (raymond_gilmartin, merck)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (raymond_gilmartin, merck)
• OE @985 (100.0%) on 17-mar-2016 [ http://www.abc.net.au/4corners/content/2005/s1341036.htm  ] using (raymond_gilmartin, merck_and_co)

NELL has only weak evidence for items listed in grey

• acquired
• schering
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 acquired arg2" ] using (merck, schering)
• sirna_therapeutics
• CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 bought arg2" "arg1 completed the acquisition of arg2" ] using (merck, sirna_therapeutics)
• agentcollaborateswithagent
• capital
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (merck, limited)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (limited, merck)
• richard_clark (personafrica)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (merck, richard_clark)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (richard_clark, merck)
• agentcontrols
• engineering (academicfield)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 ceo arg2" ] using (merck, engineering)
• officer (jobposition)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• richard_clark (personafrica)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman arg2" "arg1 chief executive arg2" "arg1 president and CEO arg2" "arg1 CEO and president arg2" "arg1 President and CEO arg2" ] using (merck, richard_clark)
• agentcreated
• norfloxacin (archaea)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, norfloxacin)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, norfloxacin)
• enalapril (drug)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, enalapril)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, enalapril)
• temodar (videogame)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, temodar)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, temodar)
• OE @1003 (100.0%) on 01-jul-2016 [ http://www.parentherald.com/articles/26337/20160308/celldex-therapeutics-abandoned-study-brain-cancer-vaccine-rintega.htm  ] using (merck_and_co, temodar)
• agentworkedondrug
• avandia
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg2 voluntarily withdraw arg1" ] using (avandia, merck)
• bextra
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg2 voluntarily withdrew arg1" ] using (bextra, merck)
• covera_hs
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (covera_hs, merck)
• efavirenz
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is marketed by arg2" ] using (efavirenz, merck)
• erbitux
• SEAL @269 (50.0%) on 24-may-2011 [ 1 ] using (erbitux, merck)
• gardasil
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 is a drug developed by arg2" ] using (gardasil, merck___co)
• SEAL @512 (50.0%) on 16-feb-2012 [ 1 ] using (gardasil, merck)
• prilosec
• SEAL @601 (50.0%) on 24-jun-2012 [ 1 ] using (prilosec, merck)
• viagra
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (viagra, merck)
• hasofficeincity
• elkton (city)
• CPL @1109 (75.0%) on 12-jun-2018 [ "arg1 Chemical plant in arg2" "arg1 and Company in arg2" ] using (merck, elkton)
• headquarteredin
• elkton (city)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Chemical plant in arg2" "arg1 and Company in arg2" ] using (merck, elkton)
• seattle (city)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Pharmaceuticals in arg2" ] using (merck, seattle)
• organizationhiredperson
• richard_clark (personafrica)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:organizationleadbyperson" "Y~_X0~concept:organizationrepresentedbyagent" "Y~_X0~concept:organizationleadbyagent" "Y~_X0~concept:controlledbyagent" "Y~_X0~concept:proxyof" ] using (merck, richard_clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:organizationleadbyperson" "Y~_X0~concept:organizationrepresentedbyagent" "Y~_X0~concept:organizationleadbyagent" "Y~_X0~concept:controlledbyagent" "Y~_X0~concept:proxyof" ] using (merck_and_co, richard_clark)
• organizationterminatedperson
• richard_clark (personafrica)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck_and_co, richard_clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck, richard_clark)
• synonymfor
• zocor_
• CPL @1095 (50.0%) on 17-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, zocor_)
• CPL @1095 (50.0%) on 17-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (zocor_, merck)
• fosamax (drug)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (fosamax, merck)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, fosamax)
• propecia
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, propecia)
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (propecia, merck)
• acquired
• inspire
• CPL @1100 (75.0%) on 31-jan-2018 [ "arg1 acquired arg2" "arg1 bought arg2" ] using (merck, inspire)
• rosetta_inpharmatics
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 acquired arg2" "arg1 and its wholly owned subsidiary arg2" ] using (merck, rosetta_inpharmatics)
• sirna (biotechcompany)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 bought arg2" "arg1 acquired arg2" "arg1 agreed to buy arg2" ] using (merck, sirna)
• rosetta (book)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg2 was acquired by arg1" ] using (merck, rosetta)
• rosetta (musicsong)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg2 was acquired by arg1" ] using (merck, rosetta)
• sirna (protein)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 bought arg2" "arg1 acquired arg2" "arg1 agreed to buy arg2" ] using (merck, sirna)
• agentcollaborateswithagent
• officer (animal)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• officer (clothing)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• officer (emotion)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• officer (eventoutcome)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• limited (filmfestival)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (merck, limited)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (limited, merck)
• officer (jobposition)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• management
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (merck, limited)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (limited, merck)
• richard_clark (personasia)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (merck, richard_clark)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 chairman arg1" "arg2 chief executive arg1" "arg2 president and CEO arg1" "arg2 CEO and president arg1" "arg2 President and CEO arg1" ] using (richard_clark, merck)
• limited (profession)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (merck, limited)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (limited, merck)
• limited (retailstore)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (merck, limited)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (limited, merck)
• officer (weapon)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• limited (year)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (merck, limited)
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jobs and arg2" ] using (limited, merck)
• agentcontrols
• engineering (agent)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 ceo arg2" ] using (merck, engineering)
• officer (animal)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• officer (clothing)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• officer (emotion)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• officer (eventoutcome)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• engineering (perceptionaction)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 ceo arg2" ] using (merck, engineering)
• richard_clark (personasia)
• CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 chairman arg2" "arg1 chief executive arg2" "arg1 president and CEO arg2" "arg1 CEO and president arg2" "arg1 President and CEO arg2" ] using (merck, richard_clark)
• engineering (researchproject)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 ceo arg2" ] using (merck, engineering)
• officer (weapon)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• agentcreated
• caspofungin (archaea)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, caspofungin)
• OE @1012 (100.0%) on 17-aug-2016 [ http://jcm.asm.org/content/47/12/4043.full http://www.bioline.org.br/request?ph10003  ] using (merck_and_co, caspofungin)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, caspofungin)
• famotidine (archaea)
• OE @1003 (100.0%) on 01-jul-2016 [ http://www.slideshare.net/sridharsri5661/formulation-and-evaluation-of-fast-dissolving-tablet-by-aryan-and-rajesh  ] using (merck_and_co, famotidine)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, famotidine)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, famotidine)
• fosamax (biotechcompany)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, fosamax)
• OE @985 (100.0%) on 17-mar-2016 [ http://www.huffingtonpost.com/martha-rosenberg/are-you-taking-pills-you-_b_920990.html  ] using (merck_and_co, fosamax)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, fosamax)
• fosamax (bone)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, fosamax)
• OE @985 (100.0%) on 17-mar-2016 [ http://www.huffingtonpost.com/martha-rosenberg/are-you-taking-pills-you-_b_920990.html  ] using (merck_and_co, fosamax)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, fosamax)
• emend (videogame)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, emend)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, emend)
• famotidine (videogame)
• OE @1003 (100.0%) on 01-jul-2016 [ http://www.slideshare.net/sridharsri5661/formulation-and-evaluation-of-fast-dissolving-tablet-by-aryan-and-rajesh  ] using (merck_and_co, famotidine)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, famotidine)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, famotidine)
• januvia (videogame)
• OE @1012 (92.3%) on 17-aug-2016 [ http://www.bloomberg.com/news/articles/2015-09-16/merck-s-once-weekly-diabetes-pill-is-as-good-as-januvia-in-study http://www.mercknewsroom.com/news-release/prescription-medicine-news/tecos-mercks-cardiovascular-safety-trial-januvia-sitagliptin http://www.bloomberg.com/news/articles/2015-08-21/merck-s-diabetes-dominance-at-risk-as-rival-drug-helps-out-heart http://www.mercknewsroom.com/news-release/prescription-medicine-news/merck-announces-trial-evaluating-cardiovascular-outcomes-sit http://www.mercknewsroom.com/news-release/prescription-medicine-news/tecos-mercks-cardiovascular-safety-trial-januvia-sitagliptin http://www.mercknewsroom.com/news-release/prescription-medicine-news/tecos-mercks-cardiovascular-safety-trial-januvia-sitagliptin http://www.fiercepharma.com/pharma/januvia-holds-off-sglt2s-to-keep-merck-s-q2-line http://www.bloomberg.com/news/articles/2015-08-21/merck-s-diabetes-dominance-at-risk-as-rival-drug-helps-out-heart http://www.bloomberg.com/news/articles/2015-09-16/merck-s-once-weekly-diabetes-pill-is-as-good-as-januvia-in-study  ] using (merck, januvia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, januvia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, januvia)
• OE @964 (100.0%) on 13-dec-2015 [ http://injurylawyer-news.com/category/januvia-byetta/  ] using (merck_and_co, januvia)
• pegintron (videogame)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck, pegintron)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentinvolvedwithitem" "Y~_X0~concept:agentinvolvedwithitem,concept:iteminvolvedwithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agentinteractswithagent,concept:agentcollaborateswithagent,concept:agentinvolvedwithitem" "Y~_X0~concept:agenthierarchicallyaboveagent,concept:subpartoforganization,concept:agentinvolvedwithitem" ] using (merck_and_co, pegintron)
• hasofficeincity
• whitehouse_station (biotechcompany)
• SEAL @25 (50.0%) on 20-jan-2010 [ 1 ] using (merck, whitehouse_station)
• SEAL @382 (50.0%) on 10-aug-2011 [ 1 ] using (merck___co, whitehouse_station)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg1 and Company of arg2" "arg1 Headquarters in arg2" "arg1 Research Laboratories in arg2" "arg1 global headquarters in arg2" ] using (merck, whitehouse_station)
• OE @997 (99.7%) on 27-may-2016 [ http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.mercknewsroom.com/news-release/corporate-news/merck-updates-plans-headquarters-move-new-jersey http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html  ] using (merck, whitehouse_station)
• elkton (blog)
• CPL @1109 (75.0%) on 12-jun-2018 [ "arg1 Chemical plant in arg2" "arg1 and Company in arg2" ] using (merck, elkton)
• new_jersey (bridge)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 Headquarters in arg2" "arg1 Pharmaceuticals of arg2" "arg1 Research Laboratories in arg2" ] using (merck, new_jersey)
• united_states (geopoliticallocation)
• CPL @1108 (75.0%) on 07-jun-2018 [ "arg1 and Company in arg2" "arg1 Research Laboratories in arg2" ] using (merck, united_states)
• state
• CPL @1108 (75.0%) on 07-jun-2018 [ "arg1 and Company in arg2" "arg1 Research Laboratories in arg2" ] using (merck, united_states)
• state001
• CPL @1108 (75.0%) on 07-jun-2018 [ "arg1 and Company in arg2" "arg1 Research Laboratories in arg2" ] using (merck, united_states)
• september
• CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 Research Laboratories in arg2" "arg1 Laboratories in arg2" ] using (merck, september)
• new_jersey (newspaper)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 Headquarters in arg2" "arg1 Pharmaceuticals of arg2" "arg1 Research Laboratories in arg2" ] using (merck, new_jersey)
• new_jersey (radiostation)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 Headquarters in arg2" "arg1 Pharmaceuticals of arg2" "arg1 Research Laboratories in arg2" ] using (merck, new_jersey)
• new_jersey (stateorprovince)
• CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 Headquarters in arg2" "arg1 Pharmaceuticals of arg2" "arg1 Research Laboratories in arg2" ] using (merck, new_jersey)
• united_states (visualartmovement)
• CPL @1108 (75.0%) on 07-jun-2018 [ "arg1 and Company in arg2" "arg1 Research Laboratories in arg2" ] using (merck, united_states)
• headquarteredin
• whitehouse_station (biotechcompany)
• OE @992 (92.0%) on 27-apr-2016 [ http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.mercknewsroom.com/news-release/corporate-news/merck-updates-plans-headquarters-move-new-jersey http://www.njbiz.com/article/20121009/NJBIZ01/121009841/Merck-announces-it's-moving-its-headquarters-to-Summit http://www.njbiz.com/article/20131001/NJBIZ01/131009988/Merck-to-cut-8500-jobs;-will-move-HQ-to-Kenilworth-not-Summit-as-previously-announced http://www.nj.com/business/index.ssf/2013/10/merck_headquarters_in_whitehou.html  ] using (merck, whitehouse_station)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 and Company of arg2" "arg1 Pharmaceuticals in arg2" "arg1 global headquarters in arg2" ] using (merck, whitehouse_station)
• SEAL @113 (75.0%) on 03-jun-2010 [ 1 2 ] using (merck, whitehouse_station)
• elkton (blog)
• CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 Chemical plant in arg2" "arg1 and Company in arg2" ] using (merck, elkton)
• new_jersey (bridge)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 Pharmaceuticals of arg2" "arg1 Pharmaceutical in arg2" "arg1 Pharmaceuticals in arg2" ] using (merck, new_jersey)
• japan (company)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 Research Labs in arg2" "arg1 Research Laboratories in arg2" ] using (merck, japan)
• japan001
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 Research Labs in arg2" "arg1 Research Laboratories in arg2" ] using (merck, japan)
• japan (country)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 Research Labs in arg2" "arg1 Research Laboratories in arg2" ] using (merck, japan)
• seattle (county)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Pharmaceuticals in arg2" ] using (merck, seattle)
• wilson (county)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Pharmaceutical in arg2" ] using (merck, wilson)
• wilson (female)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Pharmaceutical in arg2" ] using (merck, wilson)
• united_states (geopoliticallocation)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 and Company in arg2" ] using (merck, united_states)
• wilson (judge)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Pharmaceutical in arg2" ] using (merck, wilson)
• state
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 and Company in arg2" ] using (merck, united_states)
• state001
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 and Company in arg2" ] using (merck, united_states)
• japan (male)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 Research Labs in arg2" "arg1 Research Laboratories in arg2" ] using (merck, japan)
• august
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 and Company in arg2" ] using (merck, august)
• december (month)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 Pharmaceuticals in arg2" ] using (merck, december)
• july
• CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Pharmaceuticals in arg2" ] using (merck, july)
• september
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Laboratories in arg2" ] using (merck, september)
• wilson (musician)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Pharmaceutical in arg2" ] using (merck, wilson)
• new_jersey (newspaper)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 Pharmaceuticals of arg2" "arg1 Pharmaceutical in arg2" "arg1 Pharmaceuticals in arg2" ] using (merck, new_jersey)
• wilson (person)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Pharmaceutical in arg2" ] using (merck, wilson)
• new_jersey (radiostation)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 Pharmaceuticals of arg2" "arg1 Pharmaceutical in arg2" "arg1 Pharmaceuticals in arg2" ] using (merck, new_jersey)
• new_jersey (stateorprovince)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 Pharmaceuticals of arg2" "arg1 Pharmaceutical in arg2" "arg1 Pharmaceuticals in arg2" ] using (merck, new_jersey)
• december (televisionshow)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 Pharmaceuticals in arg2" ] using (merck, december)
• united_states (visualartmovement)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 and Company in arg2" ] using (merck, united_states)
• wilson (writer)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Pharmaceutical in arg2" ] using (merck, wilson)
• inverseofpersonmovedtostateorprovince
• michael (male)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Miller of arg2" ] using (michael, merck)
• organizationhiredperson
• richard_clark (personasia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:organizationleadbyperson" "Y~_X0~concept:organizationrepresentedbyagent" "Y~_X0~concept:organizationleadbyagent" "Y~_X0~concept:controlledbyagent" "Y~_X0~concept:proxyof" ] using (merck, richard_clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:organizationleadbyperson" "Y~_X0~concept:organizationrepresentedbyagent" "Y~_X0~concept:organizationleadbyagent" "Y~_X0~concept:controlledbyagent" "Y~_X0~concept:proxyof" ] using (merck_and_co, richard_clark)
• organizationterminatedperson
• richard_clark (personasia)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck_and_co, richard_clark)
• PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:proxyof,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:mutualproxyfor,concept:agentcontrols,concept:organizationhastopmember" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:worker" "Y~_X0~concept:synonymfor,concept:synonymfor,concept:organizationhasperson" "Y~_X0~concept:proxyof,concept:topmemberoforganization,concept:organizationleadbyperson" ] using (merck, richard_clark)
• synonymfor
• fosamax (biotechcompany)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (fosamax, merck)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, fosamax)
• fosamax (bone)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (fosamax, merck)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 is a registered trademark of arg2" ] using (merck, fosamax)
• agentcollaborateswithagent
• officer (animal)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (officer, merck)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 chief executive arg2" ] using (merck, officer)
• inverseofpersonmovedtostateorprovince
• michael (person)
• CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Miller of arg2" ] using (michael, merck)
• locationcontainslocation
• new
• CPL @1113 (75.0%) on 03-aug-2018 [ "arg1 York is arg2" "arg1 Zealand and arg2" ] using (new, merck)